Total Assets$XTALPI(02228.HK) Today, XtalPi (2228.HK), a global leading platform company driven by artificial intelligence (AI) and robotic automated experimental technology for R&D innovation, announced that it has successfully delivered a set of intelligent, automated robotic laboratories for drug discovery and process optimization to the leading Korean pharmaceutical company JW Pharmaceutical (001060.KS), and the project has passed full acceptance. This collaboration marks the first large-scale implementation of XtalPi's AI-powered autonomous experimental platform at an overseas pharmaceutical company, with a total value in the tens of millions of RMB. It signifies that its scientific intelligence (AI for Science) technology platform, driven by both intelligent algorithms and large-scale robotic experiments, has gained recognition and favor from international pharmaceutical companies, further validating the company's capabilities in global business expansion and delivery, as well as its technological leadership in the global AI-driven drug R&D market.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
